CG Oncology Inc. Common s... (CGON)
19.48
-2.76 (-12.41%)
At close: Apr 03, 2025, 12:31 PM
CG Oncology Common stock Revenue
CG Oncology Common stock reported an annual revenue of $1.14M, reflecting a 458.33% growth. For the quarter ending December 31, 2024, CG Oncology Common stock generated $456K in revenue.
Revenue (ttm)
$1.14M
Revenue Growth
458.33%
Price / Sales Ratio
1573.67
Revenue / Employee
$10.08K
Employees
113
Market Cap
1.48B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 1.14M | +458.33% |
| Dec 31, 2023 | 204K | +6.81% |
| Dec 31, 2022 | 191K | -98.16% |
| Dec 31, 2021 | 10.36M | n/a |